Literature DB >> 34118560

Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia.

Keane Lim1, Oon-Him Peh1, Zixu Yang1, Gurpreet Rekhi1, Attilio Rapisarda2, Yuen-Mei See1, Nur Amirah Abdul Rashid1, Mei-San Ang1, Sara-Ann Lee1, Kang Sim1, Hailiang Huang3, Todd Lencz4, Jimmy Lee5, Max Lam6.   

Abstract

Although the Positive and Negative Syndrome Scale (PANSS) is widely utilized in schizophrenia research, variability in specific item loading exist, hindering reproducibility and generalizability of findings across schizophrenia samples. We aim to establish a common PANSS factor structure from a large multi-ethnic sample and validate it against a meta-analysis of existing PANSS models. Schizophrenia participants (N = 3511) included in the current study were part of the Singapore Translational and Clinical Research Program (STCRP) and the Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). Exploratory Factor Analysis (EFA) was conducted to identify the factor structure of PANSS and validated with a meta-analysis (N = 16,171) of existing PANSS models. Temporal stability of the PANSS model and generalizability to individuals at ultra-high risk (UHR) of psychosis were evaluated. A five-factor solution best fit the PANSS data. These were the i) Positive, ii) Negative, iii) Cognitive/disorganization, iv) Depression/anxiety and v) Hostility factors. Convergence of PANSS symptom architecture between EFA model and meta-analysis was observed. Modest longitudinal reliability was observed. The schizophrenia derived PANSS factor model fit the UHR population, but not vice versa. We found that two other domains, Social Amotivation (SA) and Diminished Expression (DE), were nested within the negative symptoms factor. Here, we report one of the largest transethnic factorial structures of PANSS symptom domains (N = 19,682). Evidence reported here serves as crucial consolidation of a common PANSS structure that could aid in furthering our understanding of schizophrenia.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exploratory factor analysis; Factor structure; Meta-analysis; PANSS; Schizophrenia

Year:  2021        PMID: 34118560     DOI: 10.1016/j.ajp.2021.102732

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  4 in total

1.  Haptoglobin in ultra-high risk of psychosis - Findings from the longitudinal youth at risk study (LYRIKS).

Authors:  Jie Yin Yee; Si Qing Chow; Keane Lim; Wilson Goh; Judy Sng; Tih-Shin Lee; Jimmy Lee
Journal:  Brain Behav Immun Health       Date:  2022-06-12

2.  Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia.

Authors:  Agnieszka Markiewicz-Gospodarek; Renata Markiewicz; Beata Dobrowolska; Ryszard Maciejewski; Bartosz Łoza
Journal:  Brain Sci       Date:  2022-06-11

3.  Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia.

Authors:  Guojun Liu; Xiaoying Zhang; Xiaoning Huo; Wei Li
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

4.  The Role and Clinical Correlates of Complex Post-traumatic Stress Disorder in People With Psychosis.

Authors:  Peter Panayi; Katherine Berry; William Sellwood; Carolina Campodonico; Richard P Bentall; Filippo Varese
Journal:  Front Psychol       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.